Rifaximin Does Not Increase the Rate of 30-Day Mortality in Patients With Cirrhosis and Daptomycin in Two National US-Based Cohorts

Related articles

1. Impact of Methylprednisolone on Short- and Long-Term Outcomes in Critically Ill Patients with Sepsis: A Cohort Study Using the MIMIC-IV Database

   This article has 5 authors:

   1. Zhenhua Huang
   2. Jiagui Zhao
   3. Qinghua Yuan
   4. Xiaoan Yang
   5. Xin Li

2. Clinical efficacy and pharmacokinetics/pharmacodynamics analysis of intravenous polymyxin B for critically ill patients with sepsis

   This article has 10 authors:

   1. Hao Li
   2. Ling-Yun Zuo
   3. Jia-hui Lin
   4. Meng-Ying Pi
   5. Xiao-Bin Lin
   6. Xiao Chen
   7. Guo-Ping Zhong
   8. Ke-jing Tang
   9. Chang-Jie Cai
   10. Yan-Zhe Xia

3. Observed Frequency and Clinical Management of Sodium Polystyrene Sul-fonate Treated Hyperkalemia in Patients with Chronic Heart Failure in a Private Center in Costa Rica

   This article has 7 authors:

   1. Esteban Zavaleta-Monestel
   2. Jose Miguel Chaverri-Fernandez
   3. Sebastián Arguedas-Chacón
   4. Jeaustin Mora-Jiménez
   5. Kevin Jose Mora-Cruz
   6. Sofia Suarez-Sanchez
   7. Diego Quesada-Loría